Corient Private Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$578M Sell
2,274,445
-392,496
-15% -$91.5M 0.8% 18
2026
Q1
$650M Sell
2,666,941
-40,628
-2% -$9.46M 0.93% 15
2025
Q4
$560M Buy
2,707,569
+110,285
+4% +$21.8M 0.76% 20
2025
Q3
$481M Buy
2,597,284
+359,649
+16% +$61.6M 0.76% 20
2025
Q2
$342M Buy
2,237,635
+822
+0% +$126K 0.45% 37
2025
Q1
$371M Sell
2,236,813
-218,090
-9% -$34.1M 0.61% 30
2024
Q4
$354M Sell
2,454,903
-340,923
-12% -$52.8M 0.59% 32
2024
Q3
$453M Buy
2,795,826
+113,687
+4% +$18.1M 0.71% 25
2024
Q2
$392M Sell
2,682,139
-127,188
-5% -$18.9M 0.68% 27
2024
Q1
$444M Sell
2,809,327
-14,216
-0.5% -$2.26M 0.79% 25
2023
Q4
$443M Buy
2,823,543
+126,730
+5% +$19.4M 0.81% 19
2023
Q3
$420M Buy
2,696,813
+54,971
+2% +$9.07M 0.97% 15
2023
Q2
$437M Sell
2,641,842
-11,580
-0.4% -$1.87M 1.01% 13
2023
Q1
$411M Buy
2,653,422
+783,429
+42% +$127M 1.1% 9
2022
Q4
$330M Buy
+1,869,993
New +$323M 1.2% 9

Other funds holding JNJ

Corient Private Wealth's JNJ Position: Q2 2026 in Review

Corient Private Wealth reduced its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, selling an estimated $91.5M and leaving 2,274,445 shares worth $578M. The position accounts for 0.8% of the portfolio, ranked #18.

Corient Private Wealth first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $650M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Corient Private Wealth held 2,274,445 shares of Johnson & Johnson worth $578M as of Q2 2026.
  • Corient Private Wealth sold 392,496 Johnson & Johnson shares in Q2 2026, an estimated $91.5M.
  • Johnson & Johnson made up 0.8% of Corient Private Wealth's portfolio in Q2 2026, its #18 holding.
  • Corient Private Wealth first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Johnson & Johnson position peaked at $650M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.